Forget Teva, Buy These 4 Drug Stocks Instead
August 11, 2017 at 14:17 PM EDT
It’s not been a good quarter for Israel-based generic drug maker, Teva Pharmaceutical Industries Limited. Teva missed on both second quarter earnings and revenues and lowered its outlook for 2017.
